The ever-increasing presence of cardiometabolic risk continues to be a significant challenge for healthcare providers in the United States (US). Current estimates suggest that approximately 23% to 38% of all adults in the US have metabolic syndrome, which is a constellation of cardiometabolic risk factors, including excessive abdominal fat, insulin resistance, inflammation, dyslipidemia, and hypertension. Patients with multiple cardiometabolic risk factors have twice the likelihood of developing and dying from cardiovascular disease (CVD) and more than seven times the risk of developing diabetes compared to those with no cardiometabolic risk factors. The global epidemic of metabolic syndrome and that of obesity, type 2 diabetes, atherosclerosis, chronic kidney disease, cardiovascular disease, and NAFLD/NASH have become modern-day health hazards across the world. Lifestyle factors, including a lack of physical activity and proper nutrition, as well as smoking, can further exacerbate the impacts of cardiometabolic risk or disease, which is showing no signs of slowing down. As such, there is an ongoing need for medical education focused on all aspects of cardiometabolic risk.
In its 17th year, the Cardiometabolic Health Congress (CMHC) was the largest, US-based, multidisciplinary conference focused solely on the management of cardiometabolic risk and the prevention of cardiovascular and metabolic disease. CMHC was chaired by top experts: Christie M. Ballantyne, Robert H. Eckel, George L. Bakris, and Anne Peters. The event was attended by over 500 cardiologists, endocrinologists, lipidologists, primary care physicians, nephrologists, and allied healthcare professionals from across the world and presented a unique opportunity to learn practical solutions to consolidate into clinical practice.
In addition to offering cutting-edge and comprehensive education, the 2022 CMHC hosted its fifth annual Scientific Poster Session, where investigators from around the world brought the latest data from current research and clinical findings to share with attendees.
Save the Date
On October 18–21, 2023, CMHC will host its 18th Annual CMHC meeting, held in Boston, MA, USA. During this three-and-a-half-day conference, world-renowned experts will present on the latest developments in cardiovascular disease, chronic kidney disease, obesity and lifestyle, type 2 diabetes, lipids, and more. The meeting will include extensive expert panel discussions and debates, as well as ample opportunities for audience Q and A, with the goal of enhancing interactions with thought leaders and helping clinicians walk away with practical advice to apply directly to patient care.
For more information about this meeting and future activities from CMHC, please visit https://www.cardiometabolichealth.org/
Correction Statement
This article has been republished with minor changes. These changes do not impact the academic content of the article.